Validating molecular target-enriched fMRI for disentangling drug effects on dopamine

Area of Science:

• Neuroscience
• Pharmacology
• Radiology

Background:

• Methylphenidate's cognitive effects are linked to dopamine and noradrenaline transporters (DAT/NET).
• The dual-regression REACT method analyzes drug-induced fMRI changes using molecular target distribution.
• REACT's molecular specificity and functional relevance required validation.

Purpose of the Study:

• To validate the REACT method for analyzing methylphenidate's effects on brain function.
• To differentiate the roles of DAT and NET in methylphenidate's impact on neural reward prediction error signaling.

Main Methods:

• Utilized a pharmaco-fMRI dataset with [18F]FDOPA PET imaging.
• Applied the REACT dual-regression approach to analyze methylphenidate's effects.
• Investigated methylphenidate's modulation of DAT and NET-related functional connectivity networks.

Main Results:

• Methylphenidate modulated both DAT and NET functional connectivity networks.
• Only DAT network modulation correlated with individual differences in dopamine synthesis capacity.
• Methylphenidate's effects on DAT connectivity in the prefrontal cortex overlapped with reward prediction error signaling.

Conclusions:

• The study validates the REACT method for isolating dopamine's role in methylphenidate's effects.
• REACT successfully distinguished DAT-specific effects related to reward processing and dopamine synthesis.
• Findings confirm REACT's utility in elucidating molecular mechanisms of psychostimulant action.